SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015881
Filing Date
2021-11-15
Accepted
2021-11-15 08:37:00
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20210930x10q.htm   iXBRL 10-Q 1372805
2 EX-31.1 nrbo-20210930xex31d1.htm EX-31.1 17150
3 EX-32.1 nrbo-20210930xex32d1.htm EX-32.1 10974
  Complete submission text file 0001558370-21-015881.txt   5412973

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20210930.xsd EX-101.SCH 39863
5 EX-101.CAL nrbo-20210930_cal.xml EX-101.CAL 34887
6 EX-101.DEF nrbo-20210930_def.xml EX-101.DEF 175518
7 EX-101.LAB nrbo-20210930_lab.xml EX-101.LAB 366569
8 EX-101.PRE nrbo-20210930_pre.xml EX-101.PRE 281486
9 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20210930x10q_htm.xml XML 853046
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 211406613
SIC: 2834 Pharmaceutical Preparations